Χώρα: Ισραήλ
Γλώσσα: Αγγλικά
Πηγή: Ministry of Health
ZOLEDRONIC ACID
NOVARTIS ISRAEL LTD
M05BA08
SOLUTION FOR INFUSION
ZOLEDRONIC ACID 5 MG / 100 ML
I.V
Required
FRESENIUS KABI AUSTRIA GmbH
ZOLEDRONIC ACID
Treatment of Paget's disease of the bone. Treatment of osteoporosis : - in post-menopausal women - in men at increased risk of fracture including those with a recent low-trauma hip fracture.Treatment and prevention of glucocorticoid-induced osteoporosis.Prevention of postmenopausal osteoporosis in women for whom bisphosphonate therapy is indicated.
2017-02-12
SH ACL APL DEC20 V2 PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 The medicine is dispensed with a doctor’s prescription only ACLASTA ® SOLUTION FOR INTRAVENOUS INFUSION (I.V.) ZOLEDRONIC ACID 5 MG/100 ML Each vial of 100 ml solution contains 5 mg zoledronic acid (anhydrous). INACTIVE AND ALLERGENIC INGREDIENTS IN THE PREPARATION - see chapter 6 “Further Information”. READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, refer to the doctor or pharmacist. This medicine has been prescribed to treat your ailment. Do not pass it on to others. It may harm them even if it seems to you that their ailment is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? Aclasta is used for: ∙ Treatment of Paget’s disease of the bone. ∙ Treatment of osteoporosis: ∘ in postmenopausal women ∘ in men who are at increased risk of fracture, including those with a recent hip fracture from a minor injury. ∙ Treatment and prevention of glucocorticoid-induced osteoporosis (a type of steroids). ∙ Prevention of postmenopausal osteoporosis in women for whom bisphosphonate therapy is indicated. THERAPEUTIC GROUP: bisphosphonates. Osteoporosis: Osteoporosis is a disease that causes thinning and weakening of the bones and is common in women after menopause, but can also occur in men. At menopause, a woman’s ovaries stop producing the female hormone estrogen, which helps keep bones healthy. After menopause, bone loss occurs, the bones become weaker and break more easily. Osteoporosis could also occur in men and women because of the long-term use of steroids, which can affect the strength of bones. Many patients with osteoporosis have no symptoms, but they are still at risk of breaking bones because osteoporosis has made their bones weaker. Decreased blood levels of sex hormones, mainly estrogens formed from androgens, also play a role in the more gradual bone loss observed Διαβάστε το πλήρες έγγραφο